Evidence map›Paper›PMID 28258196›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Downregulation of E Protein Activity Augments an ILC2 Differentiation Program in the Thymus.

Hong-Cheng Wang, Liangyue Qian, Ying Zhao, Joni Mengarelli, Indra Adrianto, Courtney G Montgomery, Joseph F Urban, Kar-Ming Fung, Xiao-Hong Sun

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Parallel origins and functions of T cells and ILCs.Clinical and experimental immunology · 2023
    Review
  8. Review
  9. Article
  10. Early Development of Innate Lymphoid Cells.Methods in molecular biology (Clifton, N.J.) · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. ILC Differentiation in the Thymus.Advances in experimental medicine and biology · 2022
    Article
  17. Overview: Themes in Innate Lymphoid Cell Biology.Advances in experimental medicine and biology · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hong-Cheng WangProgram in Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Liangyue QianProgram in Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0000-0003-0265-1985
Ying ZhaoProgram in Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Joni MengarelliProgram in Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.
Indra AdriantoProgram in Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0000-0002-9973-3057
Courtney G MontgomeryProgram in Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104.ORCID 0000-0002-9606-3772
Joseph F UrbanDiet, Genomics, and Immunology Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, United States Department of Agriculture, Beltsville, MD 20705; and.ORCID 0000-0002-1590-8869
Kar-Ming FungDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.ORCID 0000-0002-4623-9469
Xiao-Hong SunProgram in Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104; sunx@omrf.org.ORCID 0000-0002-7390-7506
Oklahoma Medical Research Foundation · USAgricultural Research Service · USUniversity of Oklahoma Health Sciences Center · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI PAUL G SPICER · 2013 to 2026
$68.2M
Understanding connective tissue development and disease with PDGFR-driven..... P20GM103636 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2013 to 2023
$26.9M
Quantitative Analysis Core P30GM110766 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2014 to 2018
$6.1M
Exploring the thymic origin of group 2 innate lymphoid cellsR01AI126851 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI SUN, XIAO-HONG · 2016 to 2020
$2.7M
NIAID NIH HHS R01 AI126851NIGMS NIH HHS P20 GM103636NIGMS NIH HHS P30 GM110766NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Innate lymphoid cells (ILCs) are important regulators in various immune responses. The current paradigm states that all newly made ILCs originate from common lymphoid progenitors in the bone marrow. Id2, an inhibitor of E protein transcription factors, is indispensable for ILC differentiation. Unexpectedly, we found that ectopically expressing Id1 or deleting two E protein genes in the thymus drastically increased ILC2 counts in the thymus and other organs where ILC2 normally reside. Further evidence suggests a thymic origin of these mutant ILC2s. The mutant mice exhibit augmented spontaneous infiltration of eosinophils and heightened responses to papain in the lung and increased ability to expulse the helminth parasite,

Indexed as

AnimalsCell DifferentiationCell LineageCell SeparationDown-RegulationFlow CytometryImmunity, InnateInhibitor of Differentiation Protein 1LymphocytesLymphoid Progenitor CellsMiceMice, Inbred C57BLMice, Mutant StrainsMice, TransgenicThymus GlandIdb1 protein, mouseInhibitor of Differentiation Protein 1

Identifiers

PMID28258196
PMCPMC5404348
OpenAlexW2741027807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.